Organovo Holdings Inc. appointed David Shapiro as a director, increasing the size of its board to eight members.
Shapiro has served as the chief medical officer of Intercept Pharmaceuticals Inc. since November 2017.
Organovo is a biotech platform company providing 3D bioprint tissues with human functionality.